LOGIN
Welcoming Video
The University Of Surabaya (Ubaya) Rector |
Executive Chief Of Nrls 2022 Committee |
Natural Resources And Life Sciences 2022
Welcoming Remark
Molecular biology has given a great impact in life science investigation. The advances in molecular biology over the last several decades have boosted research and product development in many disciplines of life science, including Biotechnolgy and Pharmacy. This advances comprise: (1) the progression of more sophisticated techniques in molecular biology with a broad, interdisciplinary applications; (2) the expanding flow of information of technical novelties and scientific discoveries across scientific community; and (3) the development of more sophisticated software and continuously updated databases. This has changed the rationale and approach of experimentations giving rise to revolutionizing discoveries in many fields od science. It has become evident that the deregulation of molecular processes in body is associated with, and in certain circumstances is the direct cause of, a wide range of pathological conditions. It is necessary to mention the biomedical relevance of molecular biology-related investigations for drug discovery and the development of a more personalized medicine. Given the rapidly changing and continuously evolving nature of the molecular biology field, we can anticipate that the revolutionary impact of molecular biology in life sciences is only at the beginning and is far from being finished.
To highlight the rapidly growing research and product development in the field of Biotechnolgy and Pharmacy, the 4th International Conference on Natural Resources and Life Sciences (NRLS)” themed Biotechnology- and pharmacy-driven research and product development is presented. Following the successful program of 1st, 2nd, and 3rd NRLS, we intend to hold the next two-day conference along with a one-day optional workshop in 4th NRLS, as a scientific forum for biotechnology and pharmacy researchers and product developers to discuss the recent advances in the fields and their application. It is a great pleasure to invite you to the forthcoming 4th NRLS Conference, which will be held virtually, on August 24th-25th 2022, and the following onsite workshop on August 26th, 2022.
Warm regards,
Tjie Kok
NRLS 2022 Committee
University of Surabaya
Scientific Committee & Editorial Boards
NRLS-BIO 2022
- Tjie Kok, S.Si., M.Si., Apt., Ph.D. (Faculty of Biotechnology – University of Surabaya, Indonesia)- Dr. Dra. Mariana Wahjudi, M.Si. (Faculty of Biotechnology – University of Surabaya, Indonesia)
- Johan Sukweenadhi, Ph.D. (Faculty of Biotechnology – University of Surabaya, Indonesia)
- Dr.rer.nat. Sulistyo Emantoko D. P. (Faculty of Biotechnology – University of Surabaya, Indonesia)
- Dr.rer.nat. Maria Goretti Marianti Purwanto (Faculty of Biotechnology – University of Surabaya, Indonesia)
- Dr. Ir. Popy Hartatie Hardjo, M.Si. (Faculty of Biotechnology – University of Surabaya, Indonesia)
- Prof. Ir. Lieke Riadi, Ph.D. (Faculty of Engineering – University of Surabaya, Indonesia)
- Elieser Tarigan, S.Si., M.Eng., Ph.D. (Faculty of Engineering – University of Surabaya, Indonesia)
- Dr.rer.nat. Theresia Desy Askitosari, S.Si., M.Biotech. (Faculty of Biotechnology – University of Surabaya, Indonesia)
- Chris Jones (School of Biological Sciences - Institute of Cardiovascular and Metabolic Research, University of Reading, England)
- Grzegorz Pasternak (Wroclaw University of Science and Technology, Poland)
- Miriam Agler-Rosenbaum (Friedrich-Schiller University, Jena, Germany)
- Prof. Dr. Sri Renukadevi Balusamy, Ph.D., (Department of Food Science and Biotechnology, Sejong University, South Korea)
NRLS-PHAR 2022
- Dr. Finna Setiawan, S.Farm., M.Si. (Faculty of Pharmacy– University of Surabaya, Indonesia)- Ike Dhiah Rochmawati, S.Farm., M.Farm-Klin., Apt. (Faculty of Pharmacy– University of Surabaya, Indonesia)
- Dr. Dra. Mariana Wahjudi, M.Si. (Faculty of Biotechnology – University of Surabaya, Indonesia)
- Dr.rer.nat. Sulistyo Emantoko D. P. (Faculty of Biotechnology – University of Surabaya, Indonesia)
- Raymond R. Tjandrawinata (Dexa Laboratories of Biomolecular Sciences, Jakarta, Indonesia)
- Wouter Hinrichs (Groningen Research Institute of Pharmacy, University of Groningen, Netherlands)
- Garnpimol C. Ritthidej (Faculty of Pharmaceutical Sciences– Chulalongkorn University, Thailand)
- Chris Jones (School of Biological Sciences - Institute of Cardiovascular and Metabolic Research, University of Reading, England)
Review Policy
The 4th NRLS committee happily invites the participants to publish their presented paper in one of the following publishers. All manuscripts will undergo the reviewing processes. Only qualified and selected papers will be published either at Atlantis Proceedings in related topics:
- Biotechnology (NRLS-BIO 2022)
Advances in Biological Sciences Research Link
Subsection: Food Biotechnology, Healthcare Biotechnology, Plant Biotechnology, Clean Energy & Environmental Sustainability
- Pharmacy (NRLS-PHAR 2022)
Atlantis Highlights in Medical Sciences Link
Subsection: Pharmaceutical Technology, Clinical and Community Pharmacy, Pharmacology & Toxicology
Please follow the guideline for Abstract link and Full manuscript link
Further information about this proceedings Link
Disclaimer:
Where applicable, Atlantis Press also take care that these proceedings are submitted to relevant indexation databases such as CPCI-S and CPCI-SSH (both part of Clarivate's Web of Science), CNKI, Google Scholar, Scopus, etc.
*Note
that Atlantis Press adheres to the ethical frameworks and guidelines of the Committee on Publication Ethics (COPE),
including the COPE Core Practices and the Principles of Transparency and Best Practice in Scholarly Publishing,
and to the IEEE Standards for conference ethics and quality control.
